Catherine Bonuccelli

BELLUS Health, Inc. is a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of cough hypersensitivity and other hypersensitization disorders. Its product BLU-5937, is being developed for the treatment of chronic cough and chronic pruritus, or chronic itch. The company was founded on June 17, 1993 and is headquartered in Laval, Canada.

Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers.

The Nemours Foundation is a pediatric health system is engaged in activities that promote higher standards of children's health. It offers a spectrum of clinical treatment, research, advocacy, and educational health and prevention services extending to families in the communities it serves. Nemours Foundation was founded in Alfred I. duPont in 1936. Its headquarters are located in Jacksonville, FL.

Part of Medtronic Plc, Medical Research Group, Inc. is a private company that designs and develops implantable technologies related to pumps and sensors used for the treatment of diabetes. The company is based in Sylmar, CA. The company was founded by Aaron Mendelsohn, Alfred E. Mann. Medical Research Group was acquired by Medtronic, Inc., part of Medtronic Plc from January 27, 2015 on August 28, 2001 for $400 million.